CANCER PATIENTS & SURVIVORS:
We Need Your Help.
BrainBaseline’s Cognitive Assessment Research & Education (CARE) program is a line of research apps designed to study and improve our understanding on how various conditions affect the brain.
The current study aims to measure the relationship between cancer and cognitive decline, sometimes referred to as “chemo brain”. Recent research indicates that cancer or cancer-related treatment may be linked to cognitive impairment during and after treatment. Little is known about the cause of the impairment and may result from the cancer, the cancer treatment, or indirectly from secondary factors such as stress, fatigue, or depression.
The focus of this initial study is gathering data on the feasibility of a cognitive assessment battery to detect cognitive declines in cancer patients and survivors. The ultimate goal is for doctors to use the cognitive assessment battery to craft better treatment plans accounting for patient cognitive health.